Now showing items 1-1 of 1

    • Article
      Icon

      Cut-off ranges of infliximab serum levels in Crohn’s disease in the clinical practice 

      Valdés Delgado, Teresa; Guerra Veloz, María Fernanda; Castro Laria, Luisa; Maldonado Pérez, Belén; Perea Amarillo, Raúl; Merino Bohórquez, Vicente; Sáez, Antonia; Caunedo Álvarez, Ángel; Argüelles Arias, Federico (Aran Ediciones S.A., 2020)
      Introduction: between 30 % and 40 % of patients treated with infliximab lose response during maintenance. Ther apeutic ...